or
Looking to list your PhD opportunities? Log in here.
Research output data provided by the Research Excellence Framework (REF)
Click here to see the results for all UK universitiesDr Nik Hodges received a BSc in Biochemistry and Biological Chemistry from the University of Nottingham, followed by an MSc and a PhD in Toxicology, where he conducted research in the laboratory of Professor Kevin Chipman on the rodent tumour promoter phenobarbitol. This experience sparked his interest in the mechanisms of cellular oxidative stress. Dr Hodges has held post-doctoral positions in Occupational Health, focusing on the genotoxic carcinogen hexavalent chromium, and in the School of Biosciences, where he worked on secondary genotoxicity as part of an AstraZeneca funded research fellowship. He is currently a Reader in the School of Biosciences at the University of Birmingham, where he lectures on various Toxicology programmes and oversees multiple modules within the MSc Toxicology course.
Dr Hodges'' research focuses on genetic toxicology, cellular oxidative stress, and the repair of oxidative DNA damage. His lab was the first to identify that the variant form of the repair protein OGG1 is repair deficient under oxidative stress, which may have significant implications for individual cancer susceptibility. His research includes investigating the cellular consequences of perturbations in redox homeostasis through various chemical and biological mechanisms. Specific areas of interest include the role of OGG1 in repairing oxidatively damaged DNA, the effects of oxidative stress induced by pro-oxidants and engineered nanoparticles, and the potential functions of cytoglobin in detoxifying reactive oxygen species and its involvement in fibrotic diseases. Additionally, Dr Hodges collaborates on research concerning the cellular properties of iron and related cylinders with cytostatic effects across different cell lines.